A germline heterozygous POLQ nonsense mutation causes hereditary colorectal cancer
Xu, N.; Zhang, D.-F.; Yang, K.; Fan, Y.; Huang, F.; Ren, J.; Bi, R.; Li, Y.; Ye, M.; Xu, M.; Zhou, Y.; Li, W.; Shi, X.; Wei, Y.; Zhang, C.; Yao, Y.-G.; Li, W.-L.
Show abstract
The causal genes for a large proportion of hereditary colorectal adenomas and early-onset colorectal cancer (CRC) remain to be identified. Here, we identified a germline heterozygous stop-gain mutation p.Arg1953X (rs150312701) of the POLQ (DNA Polymerase Theta) gene, which is co-segregated with disease status, by whole-exome sequencing of twelve hereditary CRC pedigrees. The mutation was validated in an independent pedigree, resulting in ten p.Arg1953X carriers from two CRC families. Mechanically, the heterozygous nonsense mutation led to compensated overexpression of the mRNA with wild-type POLQ allele under DNA damage stress, resulting in hyperactivation of the error-prone theta mediated end-joining (TMEJ) DNA repair pathway, which enables the survival of mutation-enriched cells. Concordantly, tumor tissues from p.Arg1953X mutation carriers showed microsatellite instability and hypermutation, and were resistant to radiotherapy. We found that an FDA-approved antibiotic Novobiocin inhibits the POLQ-mediated TMEJ pathway, eliminates the p.Arg1953X mutation-related resistance to DNA damage, finally benefits tumor radiotherapy. Collectively, we defined a POLQ-mutated CRC type and suggested for a mutation-based potential target therapeutic strategy.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- METTL3 promotes homologous recombination repair and modulates chemotherapeutic response by regulating the EGF/Rad51 axis 96%
- Exosome component 1 cleaves single-stranded DNA and sensitizes kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor 95%
- DePARylation is critical for S phase progression and cell survival 95%
Similar papers in this journal
- Targeting the mitochondrial RNA methyltransferase TRMT61B reveals new therapeutic opportunities in aneuploid cancer cells 95%
- RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence 94%
- The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers 93%
Similar papers in this journal
- Loss-of-Function genetic Screen Unveils Synergistic Efficacy of PARG Inhibition with Combined 5-Fluorouracil and Irinotecan Treatment in Colorectal Cancer 94%
- Pan-cancer proteogenomic landscape of whole-genome doubling reveals putative therapeutic targets in various cancer types 93%
- Genomic profiling of cell lines reveals hidden research bias and caveats 93%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.